Grape King Bio Ltd (1707.TW)
TWD 151.0
(0.0%)
TWD 151.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 15.51 Billion TWD | 3.05% |
| 2022 | 15.05 Billion TWD | 7.06% |
| 2021 | 14.06 Billion TWD | 7.3% |
| 2020 | 13.1 Billion TWD | 15.36% |
| 2019 | 11.35 Billion TWD | 6.68% |
| 2018 | 10.64 Billion TWD | 7.65% |
| 2017 | 9.89 Billion TWD | 3.58% |
| 2016 | 9.54 Billion TWD | 10.88% |
| 2015 | 8.61 Billion TWD | 60.41% |
| 2014 | 5.36 Billion TWD | 15.99% |
| 2013 | 4.62 Billion TWD | 19.66% |
| 2012 | 3.86 Billion TWD | 11.94% |
| 2011 | 3.45 Billion TWD | 7.95% |
| 2010 | 3.2 Billion TWD | -0.12% |
| 2009 | 3.2 Billion TWD | 23.95% |
| 2008 | 2.58 Billion TWD | 2.36% |
| 2007 | 2.52 Billion TWD | 1.67% |
| 2006 | 2.48 Billion TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 15.59 Billion TWD | 0.55% |
| 2024 Q2 | 15.04 Billion TWD | -3.51% |
| 2023 Q1 | 15.08 Billion TWD | 0.2% |
| 2023 Q3 | 14.08 Billion TWD | -8.38% |
| 2023 Q2 | 15.36 Billion TWD | 1.9% |
| 2023 FY | 15.51 Billion TWD | 3.05% |
| 2023 Q4 | 15.51 Billion TWD | 10.16% |
| 2022 FY | 15.05 Billion TWD | 7.06% |
| 2022 Q1 | 14.01 Billion TWD | -0.34% |
| 2022 Q4 | 15.05 Billion TWD | 9.91% |
| 2022 Q3 | 13.69 Billion TWD | -5.85% |
| 2022 Q2 | 14.54 Billion TWD | 3.8% |
| 2021 Q1 | 13.42 Billion TWD | 2.46% |
| 2021 FY | 14.06 Billion TWD | 7.3% |
| 2021 Q3 | 12.93 Billion TWD | -4.61% |
| 2021 Q4 | 14.06 Billion TWD | 8.74% |
| 2021 Q2 | 13.55 Billion TWD | 0.96% |
| 2020 FY | 13.1 Billion TWD | 15.36% |
| 2020 Q1 | 11.64 Billion TWD | 2.51% |
| 2020 Q2 | 11.73 Billion TWD | 0.76% |
| 2020 Q3 | 11.99 Billion TWD | 2.21% |
| 2020 Q4 | 13.1 Billion TWD | 9.28% |
| 2019 Q1 | 11.02 Billion TWD | 3.59% |
| 2019 Q2 | 10.53 Billion TWD | -4.53% |
| 2019 Q3 | 10.53 Billion TWD | 0.01% |
| 2019 Q4 | 11.35 Billion TWD | 7.86% |
| 2019 FY | 11.35 Billion TWD | 6.68% |
| 2018 FY | 10.64 Billion TWD | 7.65% |
| 2018 Q4 | 10.64 Billion TWD | 9.01% |
| 2018 Q3 | 9.76 Billion TWD | -3.36% |
| 2018 Q2 | 10.1 Billion TWD | 0.72% |
| 2018 Q1 | 10.03 Billion TWD | 1.45% |
| 2017 Q1 | 9.53 Billion TWD | -0.12% |
| 2017 FY | 9.89 Billion TWD | 3.58% |
| 2017 Q4 | 9.89 Billion TWD | 9.04% |
| 2017 Q2 | 9.71 Billion TWD | 1.87% |
| 2017 Q3 | 9.07 Billion TWD | -6.64% |
| 2016 Q1 | 8.99 Billion TWD | 4.43% |
| 2016 FY | 9.54 Billion TWD | 10.88% |
| 2016 Q3 | 8.79 Billion TWD | -5.0% |
| 2016 Q4 | 9.54 Billion TWD | 8.62% |
| 2016 Q2 | 9.25 Billion TWD | 2.91% |
| 2015 Q3 | 7.88 Billion TWD | 3.75% |
| 2015 FY | 8.61 Billion TWD | 60.41% |
| 2015 Q4 | 8.61 Billion TWD | 9.22% |
| 2015 Q2 | 7.6 Billion TWD | -1.07% |
| 2015 Q1 | 7.68 Billion TWD | 43.09% |
| 2014 Q4 | 5.36 Billion TWD | 16.75% |
| 2014 Q2 | 5.07 Billion TWD | 4.33% |
| 2014 Q1 | 4.86 Billion TWD | 5.06% |
| 2014 FY | 5.36 Billion TWD | 15.99% |
| 2014 Q3 | 4.59 Billion TWD | -9.36% |
| 2013 Q4 | 4.62 Billion TWD | 16.05% |
| 2013 Q3 | 3.98 Billion TWD | -7.01% |
| 2013 Q2 | 4.28 Billion TWD | 4.65% |
| 2013 Q1 | 4.09 Billion TWD | 5.97% |
| 2013 FY | 4.62 Billion TWD | 19.66% |
| 2012 Q1 | 3.59 Billion TWD | 4.11% |
| 2012 FY | 3.86 Billion TWD | 11.94% |
| 2012 Q2 | 3.73 Billion TWD | 3.7% |
| 2012 Q3 | 3.57 Billion TWD | -4.21% |
| 2012 Q4 | 3.86 Billion TWD | 8.24% |
| 2011 Q2 | 3.35 Billion TWD | 2.94% |
| 2011 FY | 3.45 Billion TWD | 7.95% |
| 2011 Q1 | 3.26 Billion TWD | 1.9% |
| 2011 Q4 | 3.45 Billion TWD | 9.88% |
| 2011 Q3 | 3.14 Billion TWD | -6.35% |
| 2010 FY | 3.2 Billion TWD | -0.12% |
| 2010 Q4 | 3.2 Billion TWD | 0.0% |
| 2009 FY | 3.2 Billion TWD | 23.95% |
| 2008 FY | 2.58 Billion TWD | 2.36% |
| 2007 FY | 2.52 Billion TWD | 1.67% |
| 2006 FY | 2.48 Billion TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Standard Chem & Pharm CO., LTD. | 11.18 Billion TWD | -38.638% |
| Maywufa Company Ltd. | 2.83 Billion TWD | -447.721% |
| ScinoPharm Taiwan, Ltd. | 11.72 Billion TWD | -32.336% |
| Lotus Pharmaceutical Co., Ltd. | 32.99 Billion TWD | 52.982% |
| LIWANLI Innovation Co., Ltd. | 834.17 Million TWD | -1759.547% |
| YungShin Global Holding Corporation | 11.51 Billion TWD | -34.74% |
| PhytoHealth Corporation | 2.35 Billion TWD | -559.935% |
| SCI Pharmtech, Inc. | 6.69 Billion TWD | -131.84% |
| Formosa Laboratories, Inc. | 13.63 Billion TWD | -13.755% |
| PharmaEssentia Corporation | 27.26 Billion TWD | 43.116% |
| Bora Pharmaceuticals Co., LTD. | 25.05 Billion TWD | 38.081% |